SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | – | 424 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 424 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 424 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | 0.0% | 424 | 0.0% | 0.00% | – |
| Q1 2019 | $3,000 | +50.0% | 424 | +26.6% | 0.00% | – |
| Q4 2018 | $2,000 | 0.0% | 335 | +28.8% | 0.00% | – |
| Q3 2018 | $2,000 | – | 260 | +1200.0% | 0.00% | – |
| Q1 2018 | $0 | – | 20 | -70.6% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 68 | -92.3% | 0.00% | -100.0% |
| Q2 2017 | $6,000 | -40.0% | 887 | -44.8% | 0.00% | 0.0% |
| Q4 2016 | $10,000 | -28.6% | 1,607 | -28.5% | 0.00% | 0.0% |
| Q3 2016 | $14,000 | 0.0% | 2,248 | -5.4% | 0.00% | 0.0% |
| Q2 2016 | $14,000 | -26.3% | 2,376 | -19.7% | 0.00% | -66.7% |
| Q1 2016 | $19,000 | +58.3% | 2,959 | +36.2% | 0.00% | +50.0% |
| Q4 2015 | $12,000 | – | 2,173 | +2650.6% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 79 | -96.9% | 0.00% | -100.0% |
| Q1 2015 | $12,000 | +140.0% | 2,589 | +178.1% | 0.00% | – |
| Q4 2014 | $5,000 | -88.1% | 931 | -89.4% | 0.00% | -100.0% |
| Q3 2014 | $42,000 | +121.1% | 8,771 | +154.4% | 0.01% | +150.0% |
| Q2 2014 | $19,000 | -24.0% | 3,448 | -1.2% | 0.00% | -33.3% |
| Q1 2014 | $25,000 | +525.0% | 3,490 | +485.6% | 0.00% | +200.0% |
| Q4 2013 | $4,000 | +300.0% | 596 | +319.7% | 0.00% | – |
| Q3 2013 | $1,000 | -98.7% | 142 | -99.3% | 0.00% | -100.0% |
| Q2 2013 | $79,000 | – | 20,225 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 2,718,735 | $340,500,000 | 6.32% |
| Vivo Capital, LLC | 5,900,000 | $38,173,000 | 4.21% |
| Neumann Advisory Hong Kong Ltd | 315,586 | $2,042 | 0.72% |
| Yorktown Management & Research Co Inc | 74,893 | $485,000 | 0.63% |
| Skandinaviska Enskilda Banken AB (publ) | 40,000 | $259,000 | 0.00% |
| Renaissance Technologies | 2,375,841 | $1,537,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,687 | $11,000 | 0.00% |
| NORTHERN TRUST CORP | 13,787 | $55,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 412 | $27,000 | 0.00% |